BioNTech to Boost Staff by 50% at Biggest German Vaccine Factory
- Covid vaccine maker plans to add about 250 jobs in Marburg
- Factory could start making vaccines for other diseases too
Am employee in a corridor at the BioNTech SE Covid-19 vaccine production laboratory in Marburg, Germany.
Photographer: Cyril Marcilhacy/BloombergThis article is for subscribers only.
BioNTech SE plans a 50% boost in staff at its biggest German factory this year as the omicron wave drives demand for boosters of its Covid-19 vaccine.
BioNTech will add some 250 jobs this year at the factory in Marburg, north of Frankfurt, the company said by email. Some 500 people work now at the site. Also planned is an investment of about 50 million euros ($56.5 million) as well as additional office space as BioNTech assesses options for further growth.